eletriptan 20 MG Oral Tablet

RxCUI
359493
RxNorm name
eletriptan 20 MG Oral Tablet
Display name
eletriptan 20 MG Oral Tablet
Full name
eletriptan 20 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Eletriptan HydrobromideELETRIPTAN HYDROBROMIDEApnar Pharma LP49686c51-bbd9-45f0-92b1-8ffa81612e352026-05-19Warnings, Adverse reactionsExact identifier
rxcui: 359493
Eletriptan hydrobromideELETRIPTAN HYDROBROMIDECamber Pharmaceuticals, Inc.6d412c0d-c8bd-498d-b57c-6626fb33147a2025-08-30Warnings, Adverse reactionsExact identifier
rxcui: 359493
Eletriptan hydrobromideELETRIPTAN HYDROBROMIDEZydus Lifesciences Limited481ae7d4-9e57-424a-9d07-2920954b6ddc2024-11-28Exact identifier
rxcui: 359493
Eletriptan HydrobromideELETRIPTAN HYDROBROMIDETeva Pharmaceuticals USA, Inc.62dc12ce-4f19-41c6-9593-3cae29f04af12024-11-27Warnings, Adverse reactionsExact identifier
rxcui: 359493
Eletriptan HydrobromideELETRIPTAN HYDROBROMIDEAurobindo Pharma Limitedbb5ea5df-4add-420d-88cb-6dabe116ca652024-06-03Warnings, Adverse reactionsExact identifier
rxcui: 359493
RelpaxELETRIPTAN HYDROBROMIDEViatris Specialty LLC2a501dbd-3ea8-47e4-9fcb-07035b8c8c9e2024-01-15Warnings, Adverse reactionsExact identifier
rxcui: 359493
Eletriptan hydrobromideELETRIPTAN HYDROBROMIDEZydus Pharmaceuticals USA Inc.e0dfeb1f-f0f0-449a-81ae-2c8fdddcff102023-09-18Warnings, Adverse reactionsExact identifier
rxcui: 359493
Eletriptan HydrobromideELETRIPTAN HYDROBROMIDEMylan Pharmaceuticals Inc.20276f5c-f2d6-469f-9a1b-aa254a1db21c2020-04-15Warnings, Adverse reactionsExact identifier
rxcui: 359493

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 9 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
62dc12ce-4f19-41c6-9593-3cae29f04af1eletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]311These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220241127
a65315d7-a30a-4c1f-95a9-30226e559c3deletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]39These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220211122
481ae7d4-9e57-424a-9d07-2920954b6ddceletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]37ELETRIPTAN HYDROBROMIDE TABLETS20241128
bb5ea5df-4add-420d-88cb-6dabe116ca65eletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]35These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220240603
e0dfeb1f-f0f0-449a-81ae-2c8fdddcff10eletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]35These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220230918
20276f5c-f2d6-469f-9a1b-aa254a1db21celetriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]35These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220200415
2a501dbd-3ea8-47e4-9fcb-07035b8c8c9eeletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]34These highlights do not include all the information needed to use RELPAX safely and effectively. See full prescribing information for RELPAX. RELPAX ® (eletriptan hydrobromide) tablets, for oral use Initial U.S. Approval: 200220240115
49686c51-bbd9-45f0-92b1-8ffa81612e35eletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]32These highlights do not include all the information needed to use Eletriptan Hydrobromide Tablets safely and effectively. See full prescribing information for Eletriptan Hydrobromide Tablets. Eletriptan Hydrobromide Tablets, for oral use Initial U.S. Approval: 200220260519
6d412c0d-c8bd-498d-b57c-6626fb33147aeletriptan HBr 20 MG Oral Tablet [PSN] · eletriptan 20 MG Oral Tablet [SCD] · eletriptan 20 MG (as eletriptan HBr 24.2 MG) Oral Tablet [SY]31These highlights do not include all the information needed to use ELETRIPTAN HYDROBROMIDE TABLETS safely and effectively. See full prescribing information for ELETRIPTAN HYDROBROMIDE TABLETS. ELETRIPTAN HYDROBROMIDE tablets, for oral use Initial U.S. Approval: 200220250830